PharmaShots | Incisive News in 3 Shots

Subscribe Now

ADC Biosimilar

Zydus Cadila Launches Ujvira (biosimilar- trastuzumab emtansine) for Early and Advanced HER2 Positive Breast Cancer

Zydus Cadila Launches Ujvira (biosimilar- trastuzumab emtansine) for Early and Advanced HER2 Positive Breast Cancer

May 24, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us